Prescribing

Prescribing GLP-1 receptor agonists

26 March 2025Glucagon-like peptide-1 (GLP-1) receptor agonist availability is resolved. Supply content is maintained by DHSC.

Prescribing and using thiamine to prevent refeeding syndrome

11 March 2025Intravenous thiamine for prevention of refeeding syndrome should be reserved for those with intestinal failure where the oral or enteral route is unavailable.

Managing dosage adjustments for prescribed medicines

23 January 2025Advice on managing medicines that may require dosage adjustments after they have been prescribed.

Using dental antibiotic prophylaxis for hydrocephalus shunts

13 December 2024Considerations for whether the risk of shunt infection from transient bacteraemia during invasive dental procedures warrants non-routine antibiotic prophylaxis.

Supporting system response to the ADHD medicine shortage

1 November 2024Practical advice for the system in response to the NatPSA for Attention Deficit Hyperactivity Disorder (ADHD) medicines.

Continuing management of the ADHD medicines shortage

15 July 2024Support for the system in continuing to manage supply disruption of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD).

Using St Mark’s electrolyte solution

12 June 2024St Mark’s solution is an oral rehydration solution, which maintains fluid balance in conditions like short bowel syndrome. We guide on preparation and use.

Use of nefopam for chronic pain

30 January 2024Nefopam is licensed for chronic pain relief. However, evidence to support use is limited and is not included in national guidelines.

Prescribing by generic or brand name in primary care

13 September 2022Prescribing medicines by generic name is generally preferred but there are some circumstances when brand-name prescribing is warranted.